Rybrevant (amivantamab-vmjw) is a prescription biologic drug that’s used to treat non-small cell lung cancer (NSCLC). Rybrevant comes as a solution that’s given as an infusion into a vein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback